Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 December 2019 | Story Valentino Ndaba | Photo Valentino Ndaba
Lesotho Read More
Staff members from the National University of Lesotho and the University of the Free State at the signing of the Memorandum of Understanding.

Cornelius Hagenmeier, Director of the Office for International Affairs, quoted from the 2018–2020 Internationalisation Strategy, which states, “Out of the existing partnerships and collaborations, a limited number of strategic partnerships will be identified and specifically supported. Furthermore, the development of a strategic partnership with the National University of Lesotho will be explored.”  

This agenda became official on 17 October 2019 when the National University of Lesotho and the University of the Free State signed a Memorandum of Understanding.  
 
Building bridges to reach critical regional partners
 

This ongoing organic collaboration has been evident in different spheres of our university over the past few years. Joint activities are already taking place through the Directorate for Research Development that is driving the Lesotho Highlands Water Project, the Faculty of Education, Pharmacology, Political Studies, Africa Studies, and the Afromontane Research Unit on the UFS Qwaqwa Campus. 

Delegates who represented the National University of Lesotho at the signing ceremony were the Dean of the Faculty of Health Sciences, Prof Sunny Aiyuk; Dean of the Faculty of Social Sciences, Prof Motlamelle Kapa; Dean of the Faculty of the Humanities, Prof Beatrice Ekanjume-Ilongo; and Senior Lecturer in Development Studies and Chair of the Gender Committee, Dr Mamoeketsi Ntho.  

Internationalisation, Africanisation, and decolonisation
  

The conclusion of a formal Memorandum of Understanding, which contributes towards academic growth, reflects the vision of comprehensive internationalisation at both institutions.   
 
According to the UFS Internationalisation Strategy, “Internationalisation, Africanisation and decolonisation are considered as contemporary processes. In line with the South African policy priorities, the internationalisation process at the UFS will in the future include a stronger focus on the Southern African Development Community (SADC), Africa, BRICS, and the Global South. Nevertheless, the university will continue to strengthen and expand its relations and partnerships in the Global North.”  

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept